/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

MoonLake Immunotherapeutics

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$13.33 0.0663(6.63%) MLTX at 04 Dec 2025 04:38 PM Biotechnology
Lowest Today 12.5
Highest Today 13.54
Today’s Open 12.5
Prev. Close 12.52
52 Week High 62.75
52 Week Low 5.95
Day’s Range: Low 12.5 High 13.54
52-Week Range: Low 5.95 High 62.75
1 day return -
1 Week return -2.91
1 month return +31.81
3 month return -77.66
6 month return -73.9
1 year return -74.53
3 year return +32.47
5 year return +24.09
10 year return -

Institutional Holdings

Bvf Inc 31.10

Cormorant Asset Management, LLC 13.38

FMR Inc 9.02

venBio Select Advisor LLC 6.54

T. Rowe Price Associates, Inc. 4.12

Citadel Advisors Llc 2.64

Goldman Sachs Group Inc 2.01

Westfield Capital Management Company, L.P. 1.98

Federated Hermes Inc 1.97

AllianceBernstein L.P. 1.79

T. Rowe Price Health Sciences 1.64

Fidelity Growth Compy Commingled Pl S 1.54

Paradigm Biocapital Advisors LP 1.38

Nuveen, LLC 1.25

RTW INVESTMENTS, LLC 1.17

Fidelity Growth Company Fund 1.17

Hood River Capital Management LLC 1.06

Federated Hermes Kaufmann Growth 1.05

Federated Hermes Kaufmann R 1.05

Vestal Point Capital LP 0.87

Marshall Wace Asset Management Ltd 0.83

US Small-Cap Growth II Equity Comp 0.83

Fidelity Select Health Care 0.82

Fidelity Select Biotechnology 0.82

Siren, L.L.C. 0.80

Federated Hermes Kaufmann Small Cap A 0.79

Federated Hermes Kaufmann Small Cap Grow 0.79

MEDICAL BioHealth EUR Acc 0.71

Balyasny Asset Management LLC 0.67

Fidelity Blue Chip Growth 0.62

T. Rowe Price New Horizons 0.62

CREF Stock R3 0.62

Hood River Small-Cap Growth Instl 0.56

CREF Global Equities R3 0.52

BlackRock Inc 0.52

Harbor Small Cap Growth Instl 0.51

Westfield Capital Mgt Co Sm-Cap Gr Eq 0.51

T. Rowe Price Integrated US SmCapGrEq 0.50

T. Rowe Price Integrated US Sm Gr Eq 0.50

MPM Oncology Impact Management LP 0.49

Market Status

Strong Buy: 12

Buy: 4

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 887.01 M

PB Ratio 3.2468

PE Ratio 0.0

Enterprise Value 633.27 M

Total Assets 477.93 M

Volume 1635116

Company Financials

Annual Revenue FY24:null 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:null 0.0M

Annual Profit FY24:null 0.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY24:-120680002000 -120680.0M, FY23:-45678004 -45.7M, FY22:-64506051 -64.5M, FY21:-4542654 -4.5M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q4/2024:101850 0.1M, Q3/2024:0 0.0M

Quarterly Profit Q3/2025:-745000 -0.7M, Q2/2025:-742000 -0.7M, Q1/2025:-378000 -0.4M, Q4/2024:50925 0.1M, Q3/2024:null 0.0M

Quarterly Net worth Q3/2025:-69729000 -69.7M, Q2/2025:-55220000 -55.2M, Q1/2025:-39944000 -39.9M, Q4/2024:-120606670995 -120606.7M, Q3/2024:-35390337 -35.4M

Fund house & investment objective

Company Information MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.

Organisation Biotechnology

Employees 100

Industry Biotechnology

CEO Dr. Jorge Santos da Silva Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow